Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-146,710
Closed -$66K 2143
2025
Q2
$66K Buy
146,710
+8,474
+6% +$3.69K ﹤0.01% 1101
2025
Q1
$56K Buy
+138,236
New +$88.7K ﹤0.01% 1000
2024
Q3
Sell
-13,328
Closed -$9K 1932
2024
Q2
$9K Buy
+13,328
New +$11.1K ﹤0.01% 1143
2024
Q1
Sell
-43,043
Closed -$25K 2155
2023
Q4
$25K Buy
+43,043
New +$29.7K ﹤0.01% 1289
2023
Q3
Sell
-148,213
Closed -$108K 1952
2023
Q2
$108K Buy
+148,213
New +$138K 0.01% 1027
2021
Q1
Sell
-178,488
Closed -$1.02M 2061
2020
Q4
$1.02M Buy
178,488
+77,951
+78% +$496K 0.11% 218
2020
Q3
$669K Buy
+100,537
New +$895K 0.11% 207
2019
Q4
Sell
-27,966
Closed -$10K 1904
2019
Q3
$10K Sell
27,966
-7,036
-20% -$4.59K ﹤0.01% 1351
2019
Q2
$23K Buy
+35,002
New +$29.3K ﹤0.01% 1330
2018
Q1
Sell
-3,019
Closed -$19K 2684
2017
Q4
$19K Sell
3,019
-5,443
-64% -$38K ﹤0.01% 2226
2017
Q3
$64K Buy
+8,462
New +$57.6K ﹤0.01% 2184

Other funds holding VXRT

Virtu Financial's VXRT Position: Q3 2025 in Review

Virtu Financial sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 146,710 shares — an estimated $66K sold.

Virtu Financial first reported a position in VXRT in Q3 2017 and held it in 11 quarters. The position peaked at $1.02M in Q4 2020. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Virtu Financial reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 146,710 Vaxart shares in Q3 2025, an estimated $66K.
  • Virtu Financial first reported a position in Vaxart in Q3 2017 and held it in 11 quarters.
  • Virtu Financial's Vaxart position peaked at $1.02M in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.